Etanercept-Induced Thrombocytopenia In A Patient With Ankylosing Spondylitis

Home Page
About
Submit A Journal
Submit A Conference
Submit Paper/Book
- Submit a Preprint
- Submit a Book
Contact

DAHUDER Medical Journal
Volume:2 Issue:1
Etanercept-Induced Thrombocytopenia In A Patient With Ankylosing Spondylitis

Etanercept-Induced Thrombocytopenia In A Patient With Ankylosing Spondylitis

Authors : Attlla ÖNMEZ, Gulsah ALTUN, Türkay AKBAŞ, Birgül ÖNEÇ

Pages : 28-29

View : 20 | Download : 4

Publication Date : 2022-01-29

Article Type : Other Papers

Abstract :Tumor necrosis factor-alpha insert ignore into journalissuearticles values(TNF-α);, which is produced by macrophages and activated T lymphocyte cells, plays a main role in inducing further stimulation of other inflammatory cells. Anti-TNF-α drugs are used for induction and preservation of remission in patients with Ankylosing spondylitis. Etanercept, which is one of the most used Anti-TNF-α drugs, has side effects such as cytopenia but isolated thrombocytopenia is an uncommon adverse event. We report the case of a 40-year-old man diagnosed with Ankylosing spondylitis who developed Etanercept-induced isolated thrombocytopenia.
Keywords : Thrombocytopenia, Ankylosing Spondylitis, adverse effect, biological agents

ORIGINAL ARTICLE URL

VIEW PAPER (PDF)

* There may have been changes in the journal, article,conference, book, preprint etc. informations. Therefore, it would be appropriate to follow the information on the official page of the source. The information here is shared for informational purposes. IAD is not responsible for incorrect or missing information.